-
2
-
-
84868687150
-
Self-reported adherence with the use of a device in a clinical trial as validated by electronic monitors: The VIBES study
-
Jeffrey BA, Hannan MT, Quinn EK, et al. Self-reported adherence with the use of a device in a clinical trial as validated by electronic monitors: the VIBES study. BMC Med Res Methodol 2012;12:171
-
(2012)
BMC Med Res Methodol
, vol.12
, pp. 171
-
-
Jeffrey, B.A.1
Hannan, M.T.2
Quinn, E.K.3
-
3
-
-
34250749606
-
Natural history of multiple sclerosis with childhood onset
-
DOI 10.1056/NEJMoa067597
-
Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007;356:2603-13 (Pubitemid 46961005)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.25
, pp. 2603-2613
-
-
Renoux, C.1
Vukusic, S.2
Mikaeloff, Y.3
Edan, G.4
Clanet, M.5
Dubois, B.6
Debouverie, M.7
Brochet, B.8
Lebrun-Frenay, C.9
Pelletier, J.10
Moreau, T.11
Lubetzki, C.12
Vermersch, P.13
Roullet, E.14
Magy, L.15
Tardieu, M.16
Suissa, S.17
Confavreux, C.18
-
4
-
-
84872739719
-
RebiSmart (version 1.5) device for multiple sclerosis treatment delivery and adherence
-
Lugaresi A. RebiSmart (version 1.5) device for multiple sclerosis treatment delivery and adherence. Expert Opin Drug Deliv 2013;10(2):273-83
-
(2013)
Expert Opin Drug Deliv
, vol.10
, Issue.2
, pp. 273-283
-
-
Lugaresi, A.1
-
5
-
-
79959846501
-
Supportive strategies to improve adherence to IFN beta-1b in multiple sclerosis-results of the betaPlus observational cohort study
-
Pozzilli C, Schweikert B, Ecari U, Oentrich W. Supportive strategies to improve adherence to IFN beta-1b in multiple sclerosis-results of the betaPlus observational cohort study. J Neurol Sci 2011;307:120-6
-
(2011)
J Neurol Sci
, vol.307
, pp. 120-126
-
-
Pozzilli, C.1
Schweikert, B.2
Ecari, U.3
Oentrich, W.4
-
6
-
-
0032796185
-
Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice
-
DOI 10.1016/S0149-2918(99)80026-5
-
Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-90; discussion 1073 (Pubitemid 29326165)
-
(1999)
Clinical Therapeutics
, vol.21
, Issue.6
, pp. 1074-1090
-
-
Farmer, K.C.1
-
7
-
-
52449117935
-
Steigerung der Therapietreue durch ein Therapiebegleitprogramm bei Multipler Sklerose
-
Ries S, Elias WG, Japp G, Lang M. Steigerung der Therapietreue durch ein Therapiebegleitprogramm bei Multipler Sklerose. Nervenheilkunde 2008;28:818-22
-
(2008)
Nervenheilkunde
, vol.28
, pp. 818-822
-
-
Ries, S.1
Elias, W.G.2
Japp, G.3
Lang, M.4
-
8
-
-
65749088247
-
Factors that influence adherence with disease-modifying therapy in MS
-
Treadaway K, Cutter G, Salter A, et al. Factors that influence adherence with disease-modifying therapy in MS. J Neurol 2009;256:568-76
-
(2009)
J Neurol
, vol.256
, pp. 568-576
-
-
Treadaway, K.1
Cutter, G.2
Salter, A.3
-
9
-
-
84855895068
-
Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories
-
Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012;52:275-301
-
(2012)
Annu Rev Pharmacol Toxicol
, vol.52
, pp. 275-301
-
-
Blaschke, T.F.1
Osterberg, L.2
Vrijens, B.3
Urquhart, J.4
-
10
-
-
84865973828
-
Cognitive dysfunction in multiple sclerosis
-
Guimaraes J, Sa MJ. Cognitive dysfunction in multiple sclerosis. Front Neurol 2012;3:74
-
(2012)
Front Neurol
, vol.3
, pp. 74
-
-
Guimaraes, J.1
Sa, M.J.2
-
11
-
-
78751636602
-
Long-term follow-up of clinical trials of multiple sclerosis therapies
-
Freedman MS. Long-term follow-up of clinical trials of multiple sclerosis therapies. Neurology 2011;76:S26-34
-
(2011)
Neurology
, vol.76
-
-
Freedman, M.S.1
|